Research Article

Liver Adiposity and Metabolic Profile in Individuals with Chronic Spinal Cord Injury

Table 2

Lipid profile, glucose profile, ectopic adipose tissue, and inflammation in persons with motor complete SCI.

Total, n = 22Tetra, n = 8Para, n = 14

Lipid profile
 Total cholesterol (mg/dl)150.1 ± 29.0160.4 ± 21.1144.3 ± 31.9
 TG (mg/dl)111.1 ± 54.5141.1 ± 68.293.9 ± 37.6
 LDL-C (mg/dl)92.6 ± 26.998.4 ± 23.289.3 ± 29.1
 HDL-C (mg/dl)35.0 ± 8.133.0 ± 6.536.1 ± 8.9
 Non-HDL-C (mg/dl)111.9 ± 32.3127.4 ± 16.7
 Total cholesterol: HDL-C4.4 ± 1.04.9 ± 0.7
 FFA (µM/L)363.7 ± 188.8394.1 ± 216.6346.3 ± 177.2
Metabolic profile
 Fasting glucose (mg/dl)107.1 ± 13.0, = 21114.5 ± 14.54102.5 ± 9.8, =
((mU/L)−1 min−1)8.62 ± 6.28, = 194.61 ± 6.07, n = 610.47 ± 5.67, =
(min−1)0.020 ± 0.0090.017 ± 0.0030.022 ± 0.011
 HbA1c (%)5.35 ± 0.45, = 215.61 ± 0.505.19 ± 0.34, =
 Testosterone (ng/dl)424.4 ± 159.1345.3 ± 125.5
SAT and VAT
 Trunk CSA (cm2)654.4 ± 139.6664.7 ± 166.8648.5 ± 128.0
 SAT (cm2)157.0 ± 79.6163.5 ± 103.2153.4 ± 66.7
 VAT (cm2)
105.4 ± 63.9
117.5 ± 57.2
98.4 ± 68.6
Inflammation
 TNFα (pg/ml)15.3 ± 8.016.0 ± 8.214.9 ± 8.1
 IL-6 (pg/ml)
5.89 ± 6.77
5.03 ± 5.39
6.39 ± 7.59
Liver analysis ()20713
 FSF (%)3.73 ± 2.105.34 ± 2.05
 Liver CSA (cm2)163.4 ± 31.8158.0 ± 30.5166.3 ± 33.4

Values are means ± SD; , number of participants; Tetra, tetraplegic; Para, paraplegic; LDL, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; FFA, free-fatty acids; , insulin sensitivity; , glucose effectiveness; HbA1c, glycated hemoglobin; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; TNFα, tumor necrosis factor alpha; IL-6, interleukin-6; FSF, fat signal fraction; CSA, cross-sectional area; , tetra versus para.